Last updated: March 10, 2021
Patients who are receiving dialysis or have a kidney transplant are a vulnerable population. Patients receiving dialysis are generally older with other health conditions. The majority of these patients require to attend a healthcare facility on a regular basis, which further increases their risk of exposure to Covid-19. Patients who have a kidney transplant are presumed to be at high risk as they have a suppressed immune system from the medications they are on for their transplant.
The charts below show the provisional number of patients who are receiving renal replacement therapy (RRT) for end-stage renal failure (ERF), as at 23/02/21, and have received at least the first dose of the Covid-19 vaccination up to 8th March 2021. The figures on vaccinations are provisional and are subject to change as records are updated in the Vaccine Management Tool (VMT) alongside data quality checks within the Scottish Renal Registry (SRR) data.
It is possible to report data from the VMT in near real-time, but there is a lag of one day in reporting of data from the GP practices. More information on the vaccination programme can be found here: https://publichealthscotland.scot/our-areas-of-work/covid-19/covid-19-vaccinations/
Chart 1 - Summary of First Covid-19 Vaccination of those on RRT in Scotland for ERF
Chart 2: % of patients on RRT for ERF in Scotland who have received the first Covid-19 vaccine (Split by Health Board of Residence and Modality of RRT)
Notes:
The SRR is a dynamic ‘live’ dataset therefore data is subject to change after local validations.
Patient Population: All adult patients whose RRT treatment for ERF started on or before 23 February 2021 and who were still alive on that date are included. Patients who have moved outside of Scotland and those who are lost to follow-up are excluded.
Please contact: phs.srr@phs.scot if you have any further questions.